SAMRAT PHARMACHEM
Back to Cashflow Statement
|
SAMRAT PHARMACHEM Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹0.48 Cr | ₹-11 Cr | ₹9.60 Cr | ₹-1.95 Cr | ₹-1.89 Cr |
What is the latest Cash Flow from Financing Activities ratio of SAMRAT PHARMACHEM ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹0.48 Cr |
| Mar2024 | ₹-11 Cr |
| Mar2023 | ₹9.60 Cr |
| Mar2022 | ₹-1.95 Cr |
| Mar2021 | ₹-1.89 Cr |
How is Cash Flow from Financing Activities of SAMRAT PHARMACHEM Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.48 Cr | Positive | |
| Mar2024 | ₹-11 Cr | Negative | |
| Mar2023 | ₹9.60 Cr | Positive | |
| Mar2022 | ₹-1.95 Cr | Negative | |
| Mar2021 | ₹-1.89 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹60.7 Cr | -7.6% | -5% | -36.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | -7.6% |
-5% |
-36.8% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses